查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401166

恒溫核酸增幅技術的全球市場：市場規模、佔有率、趨勢分析、機會和預測（2019-2029）

Isothermal Nucleic Acid Amplification Technology Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Technology ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球恒溫核酸增幅技術（INAAT）市場規模預計在2023年至2029年間將增加一倍以上，2029年達到84.4億美元。

由於人們越來越關注患病率上升的治療和管理、快速和簡化的檢測，全球等恒溫核酸增幅技術 (INAAT) 市場正在蓬勃發展。

領先的策略諮詢和市場研究公司BlueWeave Consulting在最近的研究中估計，2022年全球恒溫核酸增幅技術（INAAT）市場規模為42.1億美元。 BlueWeave 預測，2023-2029 年預測期內，全球等恒溫核酸增幅技術（INAAT）市場規模將以 12.29% 的複合年成長率顯著成長，2029 年達到 84.4 億美元。全球等恒溫核酸增幅技術（INAAT）市場的主要成長動力包括感染疾病率的增加。結核病、肝炎和流感等疾病是感染疾病導致死亡的主要原因，特別是在開發中國家。因此，普及快速、易於使用、針對特定疾病的測試，INAAT 解決方案有望廣泛應用。再加上單引子等溫擴增（SPIA）、恒溫環型核酸擴增（LAMP）、重組聚合酶擴增（RPA）和鏈置換擴增（SDA）等創新技術的引入，現有擴增技術的不斷進步正在創造新的技術。INAAT 產品應用的可能性。預計這些發展將在預測期內提高 INAAT 的可接受性。此外，INAAT診斷及相關產品製造商之間的策略聯盟預計將在擴大市場前景和促進行業成長方面發揮關鍵作用。然而，複雜的樣品製備和市場競爭預計將在分析期間抑制整體市場的成長。

機會－INAAT在新興市場的創新應用

恒溫核酸增幅技術(INAAT) 產品的新應用源自於現有擴增技術的快速發展，例如單引子等溫擴增(SPIA)、環介導等溫擴增(LAMP)、重組酶聚合酶擴增( RPA) 和鏈位移：它是由擴增（SDA）等創新技術引起的。一個值得注意的例子是，2022 年 6 月發表在《分析師雜誌》上的一項研究利用 LAMP 技術展示了在智慧型手機整合設備中僅使用一滴血即可快速檢測茲卡病毒。這些進步預計將在預測期內加深 INAAT 的滲透率。

COVID-19對全球等恒溫核酸增幅技術市場的影響

COVID-19大流行對全球恒溫核酸增幅技術（INAAT）市場產生了正面影響。這導致對用於識別 SARS-CoV-2（冠狀病毒）的快速、準確的測試解決方案的需求顯著增加。業內多家領先公司已宣布基於INAAT的新的COVID-19檢測產品，並獲得了美國FDA對這些產品的緊急使用核准。例如，該領域的商用產品包括 Grifols Diagnostic Solutions 的 Procleix SARS-CoV-2 檢測試劑盒和 Lucira Health 的 Lucira CHECK-IT COVID-19檢測套組。 COVID-19 大流行的挑戰所引發的策略努力預計將在預測期內顯著推動市場成長。

恒溫核酸增幅技術 (INAAT) 的全球市場 – 按應用分類

按應用分類，全球恒溫核酸增幅技術市場分為血液篩檢、感染疾病診斷和癌症領域。感染疾病診斷領域在全球特定應用等恒溫核酸增幅技術（INAAT）市場中佔有最高佔有率。由於肝炎、愛滋病毒、皰疹和流感等感染疾病呈上升趨勢，核酸擴增套件可實現高效診斷和治療，因此市場預計將擴大。擴大使用現場護理 (PoC) 診斷測試有助於感染疾病的早期管理、治療和監測，從而有助於市場擴張。此外，人們對抗菌藥物和傳染病爆發的認知和關注的提高預計將對預測期內的市場成長產生積極影響。

恒溫核酸增幅技術的全球市場－按地區

本研究報告考察了全球恒溫核酸增幅技術 (INAAT) 市場，並涵蓋五個主要地區的各個各國市場。這些地區是北美、歐洲、亞太地區、拉丁美洲和中東/非洲。北美在全球等恒溫核酸增幅技術市場中佔有最高佔有率。該地區的優勢在於慢性病的高盛行率、INAAT 的技術進步以及相對於傳統技術向 INAAT 的轉變。 2020 年，美國疾病管制與預防中心報告稱，美國美國慢性病。根據GLOBOCAN 2020資料，美國新增癌症病例2281,658例，死亡病例612,390例。此外，北美的人均醫療保健支出預計將達到3,080億美元，進一步推動市場成長。預計該地區的市場未來將繼續擴大。

競爭形勢

全球等恒溫核酸增幅技術（INAAT）市場的主要企業包括Alere, Inc. Ltd.、Hologic Inc. (Gen-Probe)、Meridian Bioscience, Inc.、Ustar Biotechnologies Ltd.、QIAGEN、Quidel Corporation、Thermo Fisher Scientific , Inc.、BD (Becton, Dickinson & Company) 與OptiGene Limited。為了進一步增加市場佔有率，這些公司正在採取各種策略，例如併購、合作、合資、授權協議和新產品發布。

該報告的詳細分析提供了有關全球恒溫核酸增幅技術（INAAT）市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供全球恒溫核酸增幅技術（INAAT）市場的最新技術趨勢以及產業見解，以協助決策者做出策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章 全球等恒溫核酸增幅技術市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 疾病盛行率上升
      • 更快、更簡單的測試
    • 抑制因素
      • 複雜的樣品製備
      • 市場競爭
    • 機會
      • 即時檢測
      • 新興市場
    • 任務
      • 監管障礙
      • 技術進步
  • 科技進步/最新發展
  • 法律規範
  • 波特五力分析

第4章 等恒溫核酸增幅技術全球市場概況

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
      • 裝置
      • 試劑
    • 依技術
      • Helicase-dependent Amplification (HDA)
      • Nicking Enzyme Amplification Reaction (NEAR)
      • Loop-mediated Isothermal Amplification (LAMP)
      • Strand Displacement Amplification (SDA)
      • Nucleic Acid Sequence-based Amplification (NASBA)
      • Transcription Mediated Amplification (TMA)
      • Single Primer Isothermal Amplification (SPIA)
      • 其他
    • 按用途
      • 驗血
      • 感染疾病診斷
      • 癌症
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美等恒溫核酸增幅技術市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲恒溫核酸增幅技術市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 歐洲其他地區

第7章亞太等恒溫核酸增幅技術市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲/紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他亞太地區

第8章拉丁美洲恒溫核酸增幅技術市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第9章 中東及非洲等恒溫核酸增幅技術市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 依技術
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他中東/非洲

第10章競爭形勢

  • 主要企業及產品列表
  • 2022年全球恒溫核酸增幅技術市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 主要策略發展（合併、收購、合作夥伴關係等）

第11章 COVID-19對全球恒溫核酸增幅技術市場的影響

第12章 公司簡介

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.（Gen-Probe）
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD（Becton, Dickinson &Company）
  • OptiGene Limited
  • 其他主要企業

第13章 關鍵策略建議

第14章調查方法

簡介目錄
Product Code: BWC231036

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size More Than Doubles During 2023-2029 to Touch USD 8.44 Billion by 2029

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is flourishing because of the increasing focus on the treatment and management of rising prevalence of diseases and faster and simplified testing.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size at USD 4.21 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size to grow at a significant CAGR of 12.29% reaching a value of USD 8.44 billion by 2029. Major growth drivers for the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include increasing prevalence of infectious diseases. Diseases such as tuberculosis, hepatitis, and influenza are major contributors to fatalities from infectious diseases, particularly in developing nations. Consequently, there is expected growth in the acceptance of INAAT solutions due to the need for swift, easy-to-use, and disease-specific testing alternatives. Ongoing advancements in existing amplification technologies, coupled with the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA), are creating new possibilities for INAAT product applications. These developments are expected to enhance the acceptance of the INAAT during the forecast period. Also, prospective strategic collaborations among manufacturers of INAAT diagnostics and related products are poised to play a pivotal role in augmenting market prospects and fostering industry growth. However, complex sample preparation and market competition are anticipated to restrain the overall market growth during the period in analysis.

Opportunity - Innovative applications of INAAT in emerging markets

Emerging applications for Isothermal Nucleic Acid Amplification Technology (INAAT) products result from the rapid evolution of existing amplification technologies and the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA). A noteworthy example is a study, published in the Analyst Journal in June 2022, utilizing the LAMP technology to demonstrate swift Zika virus testing with a smartphone-integrated device, requiring only a single blood drop. These advancements are expected to deepen the penetration of the INAAT during the forecast period.

Impact of COVID-19 on Global Isothermal Nucleic Acid Amplification Technology Market

COVID-19 pandemic had a positive impact on Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It led to notable increase in demand for swift and precise testing solutions for the identification of the SARS-CoV-2 (Corona) virus. Various major players in the industry have introduced novel COVID-19 testing products based on INAAT, obtaining emergency use approvals from the US FDA for these products. For instance, commercially available products in this sector encompass Grifols Diagnostic Solutions's Procleix SARS-CoV-2 assay and Lucira Health's Lucira CHECK-IT COVID-19 test kit. Strategic endeavors, prompted by the challenges of the COVID-19 pandemic, are expected to significantly propel market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - By Application

Based on application, the Global Isothermal Nucleic Acid Amplification Technology Market is divided into Blood Screening, Infectious Disease Diagnostics, and Cancer segments. The infectious disease diagnostics segment holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by application. The increasing incidences of infectious diseases, including hepatitis, HIV, herpes, and influenza, along with the efficient diagnosis and treatment facilitated by nucleic acid amplification kits, is expected to propel market expansion. The growing use of point-of-care (PoC) diagnostic tests aids in the early management, treatment, and monitoring of infectious diseases, contributing to market growth. Additionally, heightened awareness and attention towards antimicrobial and epidemic outbreaks are expected to positively influence market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology Market - By Region

The in-depth research report on the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology Market. The region's dominance is attributed to the high prevalence of chronic diseases, technological advancements in INAAT, and a shift towards INAAT over conventional techniques. In 2020, the Centers for Disease Control and Prevention reported around 157 million Americans with chronic diseases. The GLOBOCAN 2020 data revealed 2,281,658 new cancer cases and 612,390 fatalities in the United States. Also, the substantial per capita healthcare expenditure in North America, expected to reach USD 308 billion, further propels market growth. This region is expected to experience continued market expansion.

Competitive Landscape

Major players operating in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include Alere, Inc., bioMerieux SA, Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Meridian Bioscience, Inc., Ustar Biotechnologies Ltd., QIAGEN, Quidel Corporation, Thermo Fisher Scientific, Inc., BD (Becton, Dickinson & Company), and OptiGene Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Isothermal Nucleic Acid Amplification Technology Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising prevalence of diseases
      • 3.2.1.2. Faster and simplified testing
    • 3.2.2. Restraints
      • 3.2.2.1. Complex sample preparation
      • 3.2.2.2. Market competition
    • 3.2.3. Opportunities
      • 3.2.3.1. Point-of-Care testing
      • 3.2.3.2. Emerging markets
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory hurdles
      • 3.2.4.2. Technological advancements
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Isothermal Nucleic Acid Amplification Technology Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents
    • 4.2.2. By Technology
      • 4.2.2.1. Helicase-dependent Amplification (HDA)
      • 4.2.2.2. Nicking Enzyme Amplification Reaction (NEAR)
      • 4.2.2.3. Loop-mediated Isothermal Amplification (LAMP)
      • 4.2.2.4. Strand Displacement Amplification (SDA)
      • 4.2.2.5. Nucleic Acid Sequence-based Amplification (NASBA)
      • 4.2.2.6. Transcription Mediated Amplification (TMA)
      • 4.2.2.7. Single Primer Isothermal Amplification (SPIA)
      • 4.2.2.8. Others
    • 4.2.3. By Application
      • 4.2.3.1. Blood Screening
      • 4.2.3.2. Infectious Disease Diagnostics
      • 4.2.3.3. Cancer
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Isothermal Nucleic Acid Amplification Technology Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product
      • 5.2.4.1.2. By Technology
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product
      • 5.2.4.2.2. By Technology
      • 5.2.4.2.3. By Application

6. Europe Isothermal Nucleic Acid Amplification Technology Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product
      • 6.2.4.1.2. By Technology
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product
      • 6.2.4.2.2. By Technology
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product
      • 6.2.4.3.2. By Technology
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product
      • 6.2.4.4.2. By Technology
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product
      • 6.2.4.5.2. By Technology
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product
      • 6.2.4.6.2. By Technology
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product
      • 6.2.4.7.2. By Technology
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product
      • 6.2.4.8.2. By Technology
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product
      • 6.2.4.9.2. By Technology
      • 6.2.4.9.3. By Application

7. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product
      • 7.2.4.1.2. By Technology
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product
      • 7.2.4.2.2. By Technology
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product
      • 7.2.4.3.2. By Technology
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product
      • 7.2.4.4.2. By Technology
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product
      • 7.2.4.5.2. By Technology
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product
      • 7.2.4.6.2. By Technology
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product
      • 7.2.4.7.2. By Technology
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product
      • 7.2.4.8.2. By Technology
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product
      • 7.2.4.9.2. By Technology
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product
      • 7.2.4.10.2. By Technology
      • 7.2.4.10.3. By Application

8. Latin America Isothermal Nucleic Acid Amplification Technology Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product
      • 8.2.4.1.2. By Technology
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product
      • 8.2.4.2.2. By Technology
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product
      • 8.2.4.3.2. By Technology
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product
      • 8.2.4.4.2. By Technology
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product
      • 8.2.4.5.2. By Technology
      • 8.2.4.5.3. By Application

9. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product
      • 9.2.4.1.2. By Technology
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product
      • 9.2.4.2.2. By Technology
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product
      • 9.2.4.3.2. By Technology
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product
      • 9.2.4.4.2. By Technology
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product
      • 9.2.4.5.2. By Technology
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product
      • 9.2.4.6.2. By Technology
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product
      • 9.2.4.7.2. By Technology
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product
      • 9.2.4.8.2. By Technology
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Isothermal Nucleic Acid Amplification Technology Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Isothermal Nucleic Acid Amplification Technology Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Alere, Inc.
  • 12.2. bioMerieux SA
  • 12.3. Eiken Chemical Co. Ltd
  • 12.4. Hologic Inc. (Gen-Probe)
  • 12.5. Meridian Bioscience, Inc.
  • 12.6. Ustar Biotechnologies Ltd.
  • 12.7. QIAGEN
  • 12.8. Quidel Corporation
  • 12.9. Thermo Fisher Scientific, Inc.
  • 12.10. BD (Becton, Dickinson & Company)
  • 12.11. OptiGene Limited
  • 12.12. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations